On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

Gonorrhea is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It primarily infects the ...

And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...

The U.S. Food and Drug Administration (FDA) has approved two new antibiotics: Zoliflodacin and gepotidacin. This is the first ...

UTIs are among the most common bacterial infections worldwide, but inappropriate use and overuse of antibiotics is driving ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhoea, according to a phase 3 clinical trial published in The Lancet.

The U.S. health regulator on Friday approved Innoviva's oral antibiotic to treat gonorrhea, a common sexually transmitted ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

While the expanded approval fulfills an unmet meet in postmenopausal women, its benefits are marginal in that population.

For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea.